Home » Topics » Disease categories and therapies » Infection

Infection
RSS

RiboGene and EnzyMed to collaborate on antiinfective drug discovery

Sep. 1, 1998

Highly active and stable new carbapenems described by Meiji Seika

Aug. 31, 1998

New cephalosporin derivatives active against MRSA

Aug. 28, 1998

Wakunaga discloses new antibacterial agents in early development

Aug. 28, 1998

Scientists solve 3D structure of enzyme that confers bacterial resistance to gentamicin

Aug. 28, 1998

IMpact-RSV trial results announced at international congress

Aug. 26, 1998

Nymox progresses with development of NX-B4221

Aug. 25, 1998

Strategy to improve the bioavailability of anthelmintic agents

Aug. 24, 1998

Fluoroquinolone antibacterial available for licensing from Dong Wha

Aug. 24, 1998

Fungal enzyme inhibitors synthesized at Nippon Roche

Aug. 24, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 16, 2025.
Deals and an M&A strengthen end-of-year numbers
BioWorld
Two large deals and an acquisition, totaling about $4.64 billion in all, are helping wrap up what’s turning out to be a strong year. Through the first 11 months...
ADEL wins $1.04B Sanofi deal for tau-targeting Alzheimer’s drug
BioWorld
ADEL Inc. closed a year-end licensing deal worth up to $1.04 billion with Sanofi SA for ADEL-Y01, a specific tau-targeting Alzheimer’s disease drug candidate in a...
Radiopharm Theranostics’ RAD-101 meets brain metastases endpoints
BioWorld
Radiopharm Theranostics Ltd.’s radiotracer RAD-101 met the primary endpoint in 92% of patients in the phase IIb imaging trial in brain metastases, according to...